,
Esmo-Gi 2024

Esmo-Gi 2024. The esmo gastrointestinal cancers 2024 scientific committee will select abstracts for presentation during the congress based on the following possibilities: As of mar 29, 2024, 99 pts.


Esmo-Gi 2024

Innovating for patients today and in the future: June 27th 2024 lunresertib plus folfiri was safe and produced responses in advanced gastrointestinal tumors harboring ccne1 amplifications or fbxw7 alterations.

Esmo-Gi 2024 Images References :

More Details